The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
COMy 2023 | Challenges in treating frail, older patients with myeloma: high-risk patients & toxicity management
In this video, Jonathan Kaufman, MD, Winship Cancer Institute, Emory University, Atlanta, GA, discusses two main challenges associated with treating frail, older patients with multiple myeloma. The first challenge is how to treat high-risk patients, and Dr Kaufman notes that the ideal treatment for this patient population has not yet been identified. The second challenge is management of toxicities, particularly related to dexamethasone. Dr Kaufman explains that reducing dexamethasone dosing or removing dexamethasone entirely from treatment may be viable options, and cites researching evaluating these approaches. This interview took place at the 9th World Congress on Controversies in Multiple Myeloma (COMy) 2023, held in Paris, France.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
AbbVie, Incyte: Consultant
